Hepatitis Cis a liver infection due to thehepatitis C virus (HCV).
For some people, HCV infection only causes short-term illness.
Today, DAAs offer cure rates of more than 90%.

Deepak Sethi / Getty Images
Even so, the drugs are extremely costly.
Interferon-alfa had a cure rate of only 6%.
Each is taken by mouth, some with food and others either with or without food.

One of the most notable features of all DAAs is their price.
They are all costly.
This will help determine which DAA is the best fit for you as an individual.

In certain cases, ribavirin may also be prescribed.
The different DAA drugs work in unique ways to prevent HCV from making copies of itself.
The treatment can be considered successful,and the infection can be considered cured.

This doesn’t mean you should give up or wait until your condition gets worse before trying again.
Generally, incomes that fall at or below 500% of the FPL qualify.
Discounts can vary, but it is not uncommon to reap savings of 30% or more.

Discount Card Benefits
The benefit of drug discount cards is that there are no eligibility requirements.
You simply print out the discount card or download it onto your smartphone.
Some studies even pay their participants.
By participating in a clinical trial, you may benefit from the latest advances in medical science.
A Word From Verywell
Hepatitis C is more common than many people imagine.
Yes, insurance can cover hepatitis C treatment, although copay or coinsurance costs can vary by the insurer.
On top of this, requests for treatment are sometimes denied, particularly for economically disadvantaged people on Medicaid.
Black people in the United States are disproportionately affected by hepatitis C insurance claim denials.
Department of Health and Human Services.Hepatitis C basic information.
Henry B.Drug pricing & challenges to hepatitis C treatment access.J Health Biomed Law.
doi:10.1093/ofid/ofaa569
Department of Veteran Affairs.Hepatitis C medications: An overview for patients.
doi:10.1177/0033354920904608
Kaiser Family Foundation.Claims denials and appeals in ACA marketplace plans.
Department of Health and Human Services.Viral hepatitis in the United States: Data and trends.
RR-2):117. doi:10.15585/mmwr.rr6902a1
OptumRx.Epclusa (velpatasvir/sofosbuvir) and Harvoni (ledipasvir/sofosbuvir) first-time generics.